As a result of the tie up, patients and their attendants from over 19 countries across the Middle East and Africa can come to the hospital’s flagship locations in Chennai, Hyderabad, New Delhi, Kolkata, Ahmadabad and Bangalore to avail specially formulated fares for round-trip flights with Emirates. This facility is made available to patients from the Middle East – from countries like Bahrain, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia and UAE. Furthermore, patients from African countries including Ethiopia, Ghana, Kenya, Nigeria, Senegal, South Africa, Tanzania, Uganda, Zambia and Zimbabwe, Cote d’Ivoire can avail this facility too. “Healthcare sector is evolving and has made great progress in the last few decades. However, access to better healthcare facilities, good quality and cost related challenges still exist. Therefore, we have entered into a strategic partnership with Emirates involving patients and their companions coming to Apollo Hospitals. Furthermore, all Apollo Hospitals customers can also enjoy special Emirates fares to selected destinations. We are delighted to team-up with Emirates Airlines and reach-out to those patients who value quality healthcare,” said Dr.K.Hariprasad, CEO, Apollo Hospitals Hyderabad. The hospital’s customers from India can save up to 6 % on return Business class and up to 4% on return Economy class bookings across the Emirates network in India. They can also save up to 10 % on business class and up to 5% on Economy class bookings from selected points of origin to India. Under this partnership, travellers coming to Apollo Hospitals from the above mentioned locations can avail the special fares through the ticket booking section of the Emirates Airlines microsite using the passcode, which is mentioned within the site. Click here to know more: www.emirates.com/in/Apollo  

94 year old Mr.Nasiruddin underwent a successful hip replacement procedure at Indraprastha Apollo Hospitals, New Delhi after he suffered a fall and had injured his right hip. The surgery was a crucial one as there was only little hope of recovery considering the patient’s age. “The surgery was very challenging given the fact that he was a very elderly man and had other problems like extremely fragile bones and weak muscles”, said Dr Rajeev Sharma, Senior Consultant Orthopedics & Joint Replacement Surgeon, Indraprastha Apollo Hospitals, Delhi  

Dr. Prathap C Reddy, Chairman, Apollo Hospitals Group announced forward looking leadership reorganization at Apollo aimed at furthering its strategic goals and achieving accelerated growth over the next five years while continuing to remain focused on its core of clinical excellence. Announcing the details of this change, Dr.Prathap C Reddy, Chairman, Apollo Hospitals Group said, “As the healthcare landscape in the country and the region changes and expands, this strategic realignment, we believe, will enable Apollo to focus on growth opportunities in hospitals, pharmacies, clinics and health insurance while furthering its clinical leadership and service excellence. We aim to deepen our focus in each of these verticals as well as drive synergies between them using technology and an ecosystem focused on wellness, innovation and productivity.” Apollo Hospitals has had a strong record of leadership centered on robust business performance and commitment to its customers and shareholders. It has demonstrated consistent growth in top line and profitability driven by its focus on clinical excellence and patient care. Our greatest asset is the trust that 40 million patients from 120 countries have reposed in our clinical acumen since our inception. This in turn, increases our responsibility to deliver even greater care to our patients and customers as well as our committed family of over 70,000 members along with a team of over 8000 highly skilled doctors who work relentlessly in our pursuit of excellence. The reorganization has been designed to maximize the growth as envisaged in the strategy developed in close coordination with all our stakeholders including external consultants. Similarly, the re-designation of the four Executive Directors is in keeping with the expanded roles and additional responsibilities being assigned to them aligned with the strategy, with a view to achieving the organization’s accelerated growth agenda. Ms.Preetha Reddy will assume an expanded role and be re-designated as Executive Vice-Chairperson, Apollo Hospitals Enterprise Limited. Focused on Apollo’s core strength, she will work closely with the organization’s 8000 clinicians in reviewing global medical advancements and in introducing contemporary protocols to further enhance clinical outcomes. She will lead the organization’s thrust on continuous quality improvement processes to achieve the highest standards of patient satisfaction. Ms.Preetha will persevere to further build and strengthen engagement with doctors across the organization’s network. Considering the immense potential in international business, Ms.Preetha will directly lead this portfolio and drive Apollo’s aspiration of becoming the global healthcare destination. She will steer the Enterprise Risk Management portfolio for the company. In addition to her organizational responsibilities, Ms.Preetha will work closely with industry bodies and the State and Central Governments to advance policy matters on important healthcare issues. Ms.Suneeta Reddy has displayed deep domain knowledge and foresight in guiding Apollo’s emergence as a formidable and financially sound hospital enterprise. She will now assume the role of Managing Director, Apollo Hospitals Enterprise Limited. She will lead the corporate strategy, corporate finance, funding and investments and will leverage M&As to achieve the accelerated pace of growth and optimize profitability. Ms Suneeta will directly steer the hospital vertical and will also handle Brand and Marketing. Ms.Shobana Kamineni will assume additional responsibilities and be re-designated as Executive Vice-Chairperson, Apollo Hospitals Enterprise Limited. She will continue to spearhead Apollo Pharmacy related initiatives, which is presently the fastest growing business within AHEL. In a short span of time, Apollo Pharmacy has grown to become not just the largest pharmacy chain in the country but also acquired a unique position among the top 5 retail companies in India due to the sheer size of its retail operations and geographic presence. Ms.Shobana will oversee the planning, design and execution of new projects and lead the Apollo Global Projects Consultancy Division. Ms.Shobana continues to be a Whole Time Director on the Board of Apollo Munich Health Insurance, the company she founded. The business, we believe, has a very strong growth potential. Ms.Sangita Reddy will take charge as Joint Managing Director, Apollo Hospitals Enterprise Limited and will assume greater responsibilities which will include creating an IT enabled patient centric operation across the Apollo footprint and creating an unmatched continuum of care for patients. Ms.Sangita has always been focused on the need to create healthcare of the future and has championed the organization’s endeavours in the domain of telemedicine, e-health and mobile health. She will continue to steer Apollo’s thrust on research, innovation and healthcare initiatives. In growing the group’s retail healthcare foray, Ms.Sangita will also spearhead Retail Health, including Health & Lifestyle under Apollo Health and Lifestyle Ltd., the company running Clinics, Cradles and other retail service formats. She will lead the Human Resources and IT functions across all divisions of the Group and will continue to be the Chairperson of Apollo Knowledge, the education vertical of the group. Dr.Reddy added, “We see enormous growth opportunities on which Apollo can capitalize; this restructuring will further facilitate our objective of leveraging on the company’s leadership and current business assets and platforms to execute against these opportunities. Our primary focus at Apollo is to continue on our path of growth and profitability in existing businesses while expanding to newer geographies, develop new areas in the healthcare business and harness the potential of technology to accelerate growth and innovation thereby continuing to significantly build shareholders value. While there is no change in our capital allocation plans as already communicated earlier, we believe that this structure will enhance our ability to invest and grow each of our key business platforms as we move forward.” There would be no change in the existing terms of remuneration payable to the working Directors. The Board today also approved the appointment of Mr. Vinayak Chatterjee as an Additional Director with effect from 2nd July 2014 to hold office as an Independent Director of the Company. Dr.Reddy said, “We are delighted to have Mr.Vinayak on our Board as he brings to the fore immense versatility of experience as a strategic advisor who has guided domestic and international corporates, the Government of India, various Ministries dealing with infrastructure, as well as multilateral and bilateral institutions in the areas of infrastructure planning and implementation. He has been one of the leading proponents of the Public-Private Partnership (PPP) model for developing India’s infrastructure and I firmly believe that PPPPs which includes People participation would be key to ramping up the healthcare infrastructure in our country at an accelerated pace.”  

Apollo Hospitals and Fiji National University jointly organized the first “”Fiji – Health for all Medical Symposium””, at the Pasifika Auditorium, Fiji National University, Suva, on July 27, 2014. The Symposium was a confluence of some of the best minds from various streams of medicine like Cardiac Sciences, Neurosciences, Orthopedics, Oncology, Renal Transplant and Critical Care Nursing including Dr.Kaushik Bhattacharya, Dr.Manoj Agarwal, Dr.Rahul Lath, Dr.Rooma Sinha, Dr.Vijaya Rajkumari and Dr.Hari Krishna from Apollo Hospitals This medical symposium has received the fullest support from the Ministry of Health, Fiji. Fiji National University, one of the largest universities in the South Pacific with an illustrious history within its component parts, continues to develop, innovate and expand to provide Fiji and the region with the education and training that is most-needed. With the rise in Non-communicable diseases (NCDs) becoming a bigger problem than communicable diseases in many countries, and keeping in mind the Ministry of Health’s vision of a healthier nation, Fiji National University has partnered with the Apollo Hospitals Group and hosted this, first-of-its-kind medical symposium.

A large turnout of health conscious people thronged the premises of the Times of India office at Nandanam, Chennai. The check-up included height and weight measurement, blood pressure testing and pulmonary function test, which checks the wellbeing of the respiratory system and lung chest wall mechanics to determine whether the patient has a lung problem. The test was followed up with a free consultation with the General Physician Dr. Thilagavathy Sukumar. “Chronic coughs, coughing out blood and stark change in voice are all signs that help detecting lung cancer. Upon diagnosis, the patient should really opt for a full evaluation including an X-ray, PET scan and a CT scan. Many people refrain themselves from being tested due to the fear of knowing the complexity of the disease. This free check-up will enable people to have a broad idea about the preventive measures to be taken and be prepared in case of any early detection of the illness,” she says. Those who participated in the check-up had a positive outlook upon receiving their consultation says Mr.M.Sethukumaran, who attended the camp, “”I had taken a full heart check-up at Apollo six months ago and when I heard of this free camp, I decided to appear for this as well. These camps are a good way of making people, especially youngsters aware of their health.”” Apollo has regularly organized numerous camps, along with many marathons and health awareness talks over the years to spread awareness about early detection of cancer . Dr.T.Raja,Senior Consultant, Medical Oncology at Apollo Cancer Hospital , Chennai says, “”Lung cancer is not just contracted by smokers. Even non- smokers are equally at danger. Mutations in the cells of the lungs through genetic conditioning cause the cells to become cancerous. Early detection ensures that these changes are forced to mutate because of carcinogens that are absorbed by the lungs. We, at Apollo, believe that the early detection is the best strategy for any country to follow when it comes to tackling this illness.  

Surgeons at Apollo Hospitals, Chennai successfully attempted a multi-organ transplant, giving a middle-aged man a new liver, intestine and pancreas, on Thursday. The liver, intestine and pancreas of a 12-year-old boy, who was declared brain-dead, were transplanted to the recipient in a marathon 14-hour surgery. Dr. Anand Khakhar, Programme Director, Centre for Liver Disease and Transplantation, Apollo Hospitals Chennai, said that the recipient, a resident of Chennai, suffered from liver disease and his intestinal venous system was occluded. “”We performed a combined transplant of the liver, intestine and pancreas on him. It was a multi-visceral transplant,”” he said. The surgery commenced at 3 a.m. and ended around 5 p.m. on 28th June 2014. Four senior surgeons were part of the team that performed the surgery. Doctors said they would have to wait to see the outcome of the complex procedure.  

Apollo Hospital is to be inaugurated at Nasik on 29th June 2014. Our Chairman Dr.Prathap C Reddy is the Chief Guest at the inaugural function. Apollo Hospitals, Nashik would be a multi-superspecialty hospital offering a complete range of diagnostic and therapeutic services. All specialty and super-specialty services like Anaesthesiology, Cardiology, Critical Care etc. are available at the hospital and the hospital has on board a group of highly skilled and motivated consultants across specialties.  

Apollo Hospitals has always strongly believed in social initiatives that help transcend barriers. In keeping with this, the group has started several impactful programmes in remote areas. One among these initiatives is Apollo Total Health Nutrition Centre”” at Charala, Aragonda GP, Andhra Pradesh. A community welfare initiative with the aim of providing quality nutritional guidance and care to the families from various sections of the society . The Nutrition centre was inaugurated by Dr.Mandeep Singh in presence of Ms.Usha & Mr.Ram Naresh from Apollo Hospitals. Apollo will regularly conduct comprehensive health and nutrition camps through the “”Apollo Total Health Nutrition Centre”” at Charala, Andhra Pradesh. The Group actively leverages its knowledge and technology to the development of remote corners of the country.    

 Apollo Hospitals has been ranked amongst the top organisations to work by Gallup Great Places to Work (GGWA). This would mean that Apollo is now amongst globally recognised organisations for mastering how to engage workforce to deliver sustainable growth. The GGWA is awarded to Organizations that have performed exceptionally well in engaging their workforce and thereby leveraging that to drive business results. These organizations average a ratio of 9 engaged employees to 1 disengaged employee, which is more than five times the ratio in the U.S. and more than 16 times the ratio for workforces globally. Winning the GGWA is an achievement by itself; this award places the Apollo Family amongst the best Organisations that have partnered with Gallup. The Apollo Hospitals group was the only one to have won this during the first wave of engagement. This not only recognizes the strong Leadership of the company but also the dedication and investment of time and energy that all the employees have invested to create an engaged workforce. GGWA has reinforced Apollo’s belief in treating their “”Employees”” truly as family members. The vision of it’s leadership to drive business results by engaging it’s employees has stood true to its promise. Having been selected as one of the top organizations recognizes our effort and belief in the philosophy of workforce engagement and also reinforces our drive to take this further and create an engaged workforce and thereby satisfying patients through world class quality!!  

Apollo Hospital’s subsidiary, Sapien Biosciences will introduce several genomic tests, over the next few months, as part of its personalized medicine initiative. Genomic testing involves analyses of the patient genomes and translating insights gained from these analyses to develop better healthcare interventions by the way of better prognostic tools for improved disease screening and prevention strategies, better diagnostic tests for optimization of clinical care and better theranostic tests for personalization of treatment. The first of these tests is to be launched shortly; there shall be a clinical genomics panel for oncology that is designed to identify the mutations that drive cancer initiation and progression. Insights obtained from this test will enable prediction of the patient’s response to their medication allowing the physician to tailor the treatment to the patient’s genomic profile. Further genetic tests planned for rollout include single gene panels for specific cancers (such as BRCA1/2), other disease specific genetic testing panels (such as diabetes, autism) pharmacogenetic panels (for assessment of response to specific drugs) and peri-natal diagnosis of genetic disorders. Dr.Prathap C Reddy, Chairman, Apollo Hospitals Group said, “We believe, that such genetic tests that are increasingly being adopted worldwide, will have a major impact on the delivery of quality clinical care and we are planning to integrate them into our clinical practice, in a manner consistent with global best practices”. “Along with the cancer genomic panels, we will also be launching other panels that will enable differential diagnosis of certain heritable eye and cardiovascular diseases. Such panels will be especially helpful in identifying specific gene mutations in affected individuals. This information can in turn be used to screen unaffected members of their family for early detection and management,” he added. “We shall also be introducing, genetic testing within the preventive healthcare context under careful physician supervision and with appropriate genetic counselling support. The advent of advanced genomic analytical techniques has enabled screening for genetic predisposition to various diseases. In this context, tests that identify an individual’s risk for diseases of high relevance in the Indian population could make a significant clinical impact.”  

The Immune Dysregulation Polyendocrinopathy Enteropathy X-linked Syndrome [IPEX] is a rare genetic autoimmune disease due to mutations in the FOXP3 gene, located on the X-chromosome. Affected males are present with an early onset of severe Enteropathy , usually accompanied by Insulin-Dependent diabetes, elevated serum IgE and Dermatitis. The other autoimmune symptoms include Hypothyroidism, Anaemia, Thrombocytopenia and Neutropenia. The onset in the severe form of the disease occurs within the first month of life and can be rapidly fatal. The use of Allogeneic Haematopoietic stem cell (HSCT) transplantation has been limited but, when performed before severe autoimmunity develops, can be an effective cure. A well matched cord blood unit was identified in a New York cord blood bank and was imported to Chennai for transplantation. The new cells were transfused into Damien on 14/11/2013 and he was supported all through until his immune system was replaced entirely by the new cord blood stem cells. The child was stabilized over 8 weeks by an expert multidisciplinary team consisting Pediatric Intensivists, Endocrinologists, Gastroenterologists, Infectious Disease Specialists, Dermatologists and a team of dedicated nurses. Damien recovered over the next few weeks and soon he could talk and walk and eat new food every day. In March 2014 he returned back home happy and healthy. Team Apollo gave this child a gift a new life. Damien is now freed from the risk of infections!  

Apollo Hospitals Group is a pioneer in bringing cure through transplants. Speaking on the occasion, Prof Anupam Sibal, Group Medical Director and Senior Pediatric Gastroenterologist, Apollo hospitals, Delhi said, “we are delighted that we have been able to touch so many lives across the border. We performed the first successful liver transplant in India in 1998, the Apollo Transplant Program today has performed over 1700 liver transplants in children and adults”.